First Randomized Trial of Azacitidine w/ Durvalumab for the Front-Line Treatment of Older Pts with AML and MDS: Data Presented at ASH 2019

354 views
March 25, 2020
0 Comments
Login to view comments. Click here to Login
Hematologic Oncology